Article

Report: DME more prevalent in African-Americans

African-Americans seem to be at higher risk for diabetic macular edema (DME), according to research by the Keck School of Medicine at the University of Southern California (USC).

 

Los Angeles-African-Americans seem to be at higher risk for diabetic macular edema (DME), according to research by the Keck School of Medicine at the University of Southern California (USC).

The research-published recently in the Journal of the American Medical Association (JAMA) Ophthalmology-found a higher burden of diabetes-related vision loss among certain ethnic populations because of problems with access to care, explained corresponding author Rohit Varma, MD, MPH, director of the USC Eye Institute, professor and chairman of ophthalmology at the Keck School of Medicine of USC.

More in this issue: Valeant’s takeover attempt of Allergan continues to heat up

“We were surprised that our research showed that African-Americans have the highest rates of DME, when Hispanics tend to have the highest prevalence of diabetes,” Dr. Varma said. “There is not enough vision screening for DME among diabetics, yet there are much better therapies available that are covered by insurance.

“We hope that our research will help those in the position to influence policy to get a better handle on costs and where the need for treatment is the greatest,” he continued.

 

Dr. Varma’s team conducted the study by using the National Health and Nutrition Examination Study (NHANES) database.

The next target for research in this area, Dr. Varma said, will be examining barriers to access to eye care among African Americans.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

 

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.